| DEED | DMBS | DEED / DMBS | |
| Gain YTD | -0.106 | -0.382 | 28% |
| Net Assets | 64.2M | 699M | 9% |
| Total Expense Ratio | 0.66 | 0.39 | 169% |
| Turnover | 178.00 | 247.00 | 72% |
| Yield | 4.47 | 5.09 | 88% |
| Fund Existence | 6 years | 3 years | - |
| DEED | DMBS | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 64% | 3 days ago 62% |
| Stochastic ODDS (%) | 3 days ago 61% | 3 days ago 58% |
| Momentum ODDS (%) | 3 days ago 44% | 3 days ago 55% |
| MACD ODDS (%) | 3 days ago 51% | 3 days ago 34% |
| TrendWeek ODDS (%) | 3 days ago 56% | 3 days ago 51% |
| TrendMonth ODDS (%) | 3 days ago 57% | 3 days ago 50% |
| Advances ODDS (%) | 6 days ago 60% | 6 days ago 51% |
| Declines ODDS (%) | 3 days ago 60% | 11 days ago 47% |
| BollingerBands ODDS (%) | 3 days ago 55% | 3 days ago 61% |
| Aroon ODDS (%) | 3 days ago 62% | 3 days ago 34% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EEMRX | 11.95 | 0.26 | +2.22% |
| MFS Emerging Markets Equity Research C | |||
| ARAGX | 9.92 | 0.20 | +2.06% |
| Aristotle Growth Equity A | |||
| SIEMX | 16.84 | 0.25 | +1.51% |
| SEI Emerging Markets Equity F (SIT) | |||
| JNGLX | 88.71 | N/A | N/A |
| Janus Henderson Global Life Sciences D | |||
| VMNIX | 16.17 | -0.07 | -0.43% |
| Vanguard Market Neutral I | |||